Novartis | NVS - Market Capitalization



Novartis reported $266.15B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
AbbVie USD 327.88B 42.76B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
AstraZeneca GBP 215.51B 41B Jun/2025
Bausch Health Companies CAD 3.36B 87.55M Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Canopy Growth CAD 225.05M 88.93M Sep/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Drreddys Laboratories USD 2.37B 10.15B Sep/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Glaxosmithkline USD 82.21B 2.63B Sep/2025
J&J USD 366.71B 32.94B Jun/2025
Merck USD 198.77B 27.1B Jun/2025
Novartis CHF 256.18B 64.49B Jun/2025
Novartis USD 258.67B 24.42B Sep/2025
Pacira USD 1.11B 43M Jun/2025
Perrigo USD 3.65B 177M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Prestige Brands USD 3.93B 325M Jun/2025
Sanofi EUR 100.06B 25.78B Jun/2025
Sanofi USD 125.19B 7.59B Sep/2025
Supernus Pharmaceuticals USD 1.76B 65M Jun/2025
Zoetis USD 69.43B 4.01B Jun/2025